NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Otsuka Icu Medcl	NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER	dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate	INJECTABLE;INJECTION	017609	NDA	ICU Medical Inc.	0990-7968-09	12 BAG in 1 CASE (0990-7968-09) / 1000 mL in 1 BAG	2020-05-14
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 2, 2025

Introduction

The demand for intravenous (IV) fluid therapy remains a cornerstone in clinical medicine, supporting hydration, electrolyte balance, and medication delivery. Among the staple solutions are NORMOSOL-R and Dextrose 5%, both widely utilized in hospitals worldwide. These solutions, supplied predominantly in plastic containers for safety, convenience, and compatibility, are produced by multiple manufacturers globally. Identifying reliable suppliers with validated manufacturing standards is essential for healthcare providers, procurement officers, and licensors aiming to ensure quality, compliance, and availability.

Product Overview

NORMOSOL-R is an isotonic balanced electrolyte solution containing sodium, potassium, chloride, magnesium, and acetate/buffer components designed for volume resuscitation and electrolyte correction. It is often preferred over other saline solutions because of its physiological electrolyte composition, reducing the risk of acid-base disturbances.

Dextrose 5% in Plastic Container (commonly Dextrose 5%) is a glucose solution providing caloric energy and hydration. It’s used in various clinical scenarios, including hypoglycemia correction, fluid replacement, and drug administration. Its usability in pre-filled plastic containers enhances safety and ease of administration.

Global Suppliers of NORMOSOL-R

1. Baxter International Inc.

Baxter is a leading pharmaceutical and medical device company with a significant portfolio of IV solutions. Baxter manufactures NORMOSOL-R, sourced through its extensive global distribution network. Baxter's formulations adhere to Good Manufacturing Practices (GMP), with manufacturing plants certified under FDA, EMA, and other regulatory agencies.

Distribution: Baxter supplies NORMOSOL-R across North America, Europe, Asia-Pacific, and other regions via authorized distributors and direct sales channels.
Certifications: FDA (USA), EMA (Europe), TGA (Australia), and other local authorities.

2. Hospira (a Pfizer company)

Hospira, acquired by Pfizer, is renowned for its injectable drugs and IV fluids, including electrolyte solutions akin to NORMOSOL-R. While not always explicitly labeled as NORMOSOL-R, similar formulations are available under different brand names.

Distribution: Globally through Pfizer’s network.
Availability: Mainly in North America, with regional distribution in select Asian and European markets.

3. Local and Regional Manufacturers

In some markets, local pharmaceutical manufacturers produce NORMOSOL-R or equivalent balanced electrolyte solutions compliant with regional standards, such as:

India: Fresenius Kabi India and Local pharma companies manufacture similar formulations, compliant with WHO GMP.
China: Shanghai Pharma and others are authorized suppliers registering electrolyte solutions in line with Chinese standards.

Suppliers of Dextrose 5% in Plastic Containers

1. B. Braun Melsungen AG

A global leader in IV solutions, B. Braun supplies Dextrose 5% solutions globally, often in pre-filled plastic bottles or bags.

Distribution: Extensive network in Europe, the Americas, and Asia-Pacific.
Product features: Sterile, pyrogen-free, compatible with infusion pumps.

2. Baxter International Inc.

In addition to NORMOSOL-R, Baxter produces Dextrose 5% solutions in various container formats, including plastic bags and bottles.

Availability: Routinely stocked across North America, Europe, and other markets.

3. Fresenius Kabi

Fresenius Kabi manufactures Dextrose 5% in plastic containers, emphasizing safety, sterilization, and shelf-life stability.

Regions: Europe, Asia, and emerging markets.

4. Pfizer / Hospira

Through its global network, Pfizer supplies Dextrose 5% in prefilled plastic containers, primarily in North America and Europe.

5. Local Manufacturers

Various regional producers manufacture Dextrose solutions in plastic containers, especially in emerging markets, adhering to regional regulatory standards such as Indian Pharmacopoeia, Chinese Pharmacopoeia, or WHO GMP.

Regulatory and Quality Considerations

Procurement of IV solutions requires diligence regarding approvals and certifications:

GMP Compliance: Ensure suppliers follow Good Manufacturing Practices (GMP).
Regulatory Approvals: Verify product registration with relevant authorities (FDA, EMA, TGA, etc.).
Certification: Confirm Certificate of Suitability (CEP), Drug Master File (DMF), or equivalent documentation.
Batch Testing & Stability Reports: Providers should supply test reports confirming sterility, pyrogen-free status, and chemical stability.

Distribution Channels and Purchasing Strategies

Authorized Distributors: Engage with certified distributors to mitigate risks related to counterfeit or substandard products.
Direct Procurement: For large healthcare institutions, establishing direct supply agreements with manufacturers or regional offices offers better pricing and supply assurances.
Regional Suppliers: Utilizing regional manufacturers can reduce lead times and logistics costs, especially in localized markets.

Market Challenges and Recommendations

Supply Chain Disruptions: Global events, such as the COVID-19 pandemic, have exposed vulnerabilities; diversification of suppliers is recommended.
Regulatory Harmonization: Ensuring products meet regional standards avoids compliance issues.
Quality Assurance: Regular audits, supplier qualification, and lot testing should become standard procurement processes.

Key Takeaways

Global players like Baxter and Fresenius Kabi dominate the supply chain for NORMOSOL-R and Dextrose 5% in plastic containers, with extensive distribution networks.
Regional manufacturers are vital in ensuring local supply, particularly in emerging markets, underscoring the importance of regional regulatory compliance.
Procurement professionals should emphasize verified GMP compliance, product certification, and authorized distribution channels to secure high-quality, regulatory-compliant solutions.
Supply chain resilience can be enhanced through supplier diversification, strategic stockpiling, and maintaining relationships with multiple qualified vendors.
Automation and digital platforms facilitate ongoing supplier qualification, batch tracking, and regulatory compliance management.

FAQs

1. Are there any differences between electronically sterilized and traditional sterilization methods for IV solutions?
Yes. Electron-beam and gamma irradiation sterilization are increasingly used as they often provide faster, more consistent sterilization processes with minimal impact on solution stability, offering better control in manufacturing. Regulatory approval is required for solutions sterilized via emerging methods.

2. Can I procure NORMOSOL-R and Dextrose 5% from local suppliers?
Yes, in many regions, licensed local manufacturers produce equivalent electrolyte and glucose solutions in compliance with regional standards. Nonetheless, it is critical to verify their GMP certification and regulatory approval to ensure product safety and efficacy.

3. What certifications should I verify before purchasing IV solutions?
Manufacturers should have GMP compliance certificates, regulatory registrations (FDA, EMA, or equivalent), and product-specific certifications like CEPs or DMFs. Batch testing reports and stability data further validate quality.

4. How can supply chain disruptions affect the procurement of IV fluids?
Disruptions can lead to shortages, delays, or inflated prices. Diversifying suppliers, maintaining safety stock, and engaging with multiple authorized distributors mitigate these risks.

5. Are prefilled plastic containers safer than glass for IV solutions?
Prefilled plastic containers reduce breakage risk, ease of handling, and contamination, enhancing safety. They also facilitate compatibility with infusion pumps, improving clinical efficiency.

References

[1] Baxter International Inc. Product portfolio.
[2] Fresenius Kabi. IV solutions catalog.
[3] World Health Organization. GMP guidelines for injectable medicines.
[4] European Medicines Agency. Certification and registration of IV solutions.
[5] US Food and Drug Administration. Good Manufacturing Practices for sterile drug products.

Suppliers and packagers for NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER